SynthesisBMC cancer2025

Efficacy and safety of first-line CDK4/6 inhibitors plus AI therapy for patients with HR +/HER2- advanced breast cancer: a network meta-analysis.

Yanrong Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.